Naproxen Sodium 51316-0762
Product NDC
51316-0762- Manufacturer
- Cvs
- Dosage Form
- Tablet
- Route
- Oral
- Product Type
- Human Otc Drug
- Marketing Start
- May 25, 2024
- Listing Expires
- December 31, 2026
- Application
- ANDA091353
Active Ingredients
| Ingredient | Strength |
|---|---|
| Naproxen Sodium | 220 mg/1 |
Drug Class
Anti-Inflammatory AgentsNon-Steroidal [CS]Cyclooxygenase Inhibitors [MoA]
Packaging Options(1)
270 TABLET in 1 BOTTLE (51316-762-70)